Experienced in Angioimmunoblastic T-cell Lymphoma

Magnus Tobiasson

Stockholm, AB, SE 
Experienced in Angioimmunoblastic T-cell Lymphoma
Stockholm, AB, SE 
OverviewLocationsClinical Research

Overview

Magnus Tobiasson practices in Stockholm, Sweden. Mr. Tobiasson is rated as an Experienced expert by MediFind in the treatment of Angioimmunoblastic T-cell Lymphoma. His top areas of expertise are Myelodysplastic Syndrome (MDS), Angioimmunoblastic T-cell Lymphoma, Acute Myeloid Leukemia (AML), Leukemia, and Bone Marrow Transplant.

His clinical research consists of co-authoring 40 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Angioimmunoblastic T-cell Lymphoma.

Gender
Male

Locations

Stockholm, AB, Sweden
Other Locations
Huddinge, AB, Sweden

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

An Open Pilot Study to Assess the Pharmacokinetics, Tolerability, and Safety of NEX-18a Given as a Subcutaneous Injection for the Treatment of Intermediate 2 or Higher-risk MDS, CMML or AML
An Open Pilot Study to Assess the Pharmacokinetics, Tolerability, and Safety of NEX-18a Given as a Subcutaneous Injection for the Treatment of Intermediate 2 or Higher-risk MDS, CMML or AML
Enrollment Status: Completed
Publish Date: October 17, 2023
Intervention Type: Drug
Study Drugs: NEX-18a Injection, Azacitidine Injection
Study Phase: Phase 1

40 Total Publications

Validation of Guidelines for Genetic Investigation of Myeloid Neoplasms with Germline Predisposition: Results from a Prospective Cohort Study.
Validation of Guidelines for Genetic Investigation of Myeloid Neoplasms with Germline Predisposition: Results from a Prospective Cohort Study.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 17, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Tobiasson's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile